RecallRadar

FDA Device recall Z-0846-2014

Simplexa Flu A/B & RSV Direct assay, Model MOL2650

On 2014-02-05 the FDA classified a Class II recall of Simplexa Flu A/B & RSV Direct assay, Model MOL2650 by Focus Diagnostics, citing focus Diagnostics is initiating an urgent safety notice correction for Simplexa Flu A/B & RSV Direct assay (MOL2650) because Focus Diagnostics has received some customer complaint….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0846-2014
ClassificationClass II
Statusterminated
Initiated2014-01-10
Published2014-02-05
Last updated2026-09-13 11:53 UTC
CompanyFocus Diagnostics
DistributionUS

Product

Simplexa Flu A/B & RSV Direct assay, Model MOL2650. The Focus Diagnostics Simplexa Flu A/B & RSV Direct assay is intended for use on the 3M Integrated Cycler instrument for the in vitro qualitative detection and differentiation of influenza A virus, influenza B virus, and respiratory syncytial virus (RSV) RNA in nasopharyngeal swabs (NPS) from human patients with signs and symptoms of respiratory tract infection in conjunction with clinical and epidemiological risk factors. This test is intended for use as an aid in the differential diagnosis of influenza A, influenza B, and RSV viral infections in humans and is not intended to detect influenza C.

Reason

Focus Diagnostics is initiating an urgent safety notice correction for Simplexa Flu A/B & RSV Direct assay (MOL2650) because Focus Diagnostics has received some customer complaints of Simplexa Flu A/B & RSV lots due to sporadic false positive RSV signals, which may result in a higher RSV false positive rate.

Identifiers

code_infoModel Number MOL2650 Lot Numbers: 24493, 24495, 24535, 24536.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0846-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.